In a head-to-head RCT, Rezūm produced a 4.6-point greater IPSS improvement than combination pharmacotherapy at 1 year, according to Jean-Nicolas Cornu, MD, PhD, FEBU.
|Videos|September 19, 2021
Minimally invasive Zenflow Spring System shows promise in BPH
Author(s)Urology Times staff
Advertisement
In this video, Peter Chin, MD, discusses the excitement surrounding the minimally invasive capabilities of the investigational Zenflow Spring System for patients with BPH. Chin is an associate professor at the University of Wollongong, New South Wales, Australia.
Advertisement
Related to this article
Cameron C. Jones, MD, discusses patient selection for Aquablation, including prostate size, anatomy, and factors that may favor alternative BPH procedures.
Advertisement
Advertisement
Trending on Urology Times
1
FDA updates in urology: September 2026
2
John Sfakianos, MD, on integrating ctDNA into bladder cancer trials
3
Behind the FDA approval of belzutifan plus lenvatinib in advanced ccRCC, with Robert Motzer, MD
4
SBRT, prostatectomy show comparable long-term disease control in PACE-A trial
5